Does the calcium content of bismuth salicylate affect the efficacy of quadruple therapy for H. Pylori treatment?
No direct evidence for the impact of calcium content in bismuth salicylate on quadruple therapy efficacy exists; current therapies are effective regardless of moderate formulation variations.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-20
- DOI
- https://doi.org/10.5281/zenodo.24404692
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00